Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway smooth muscle contraction is the process by which smooth muscle cells that line the airways contract, narrowing the airway lumen and increasing airway resistance. This process is physiologically important for regulation of airflow but is exaggerated in diseases such as asthma, where it contributes to acute bronchoconstriction, airway hyperresponsiveness, and chronic airway remodeling. Airway smooth muscle cells not only contract but also play roles in immunity, cytokine secretion, and structural remodeling of the airways. Therapeutic interventions in asthma and COPD often seek to modulate the contractile state or mass of these muscle cells to improve airway function
β2-adrenoceptor agonists: induce ASM relaxation by increasing cAMP Muscarinic antagonists: block cholinergic-induced contraction PDE inhibitors: elevate cAMP levels, promoting relaxation TMEM16A inhibitors: reduce calcium-activated chloride flux and contraction Bronchial thermoplasty: reduces ASM mass by thermal ablation
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway smooth muscle cell (ASM cell).